The PRO-SELF© mouth aware program:: An effective approach for reducing chemotherapy-induced mucositis

被引:44
作者
Larson, PJ
Miaskowski, C
MacPhail, L
Dodd, MJ
Greenspan, D
Dibble, SL
Paul, SM
Ignoffo, R
机构
[1] Univ Calif San Francisco, Dept Physiol Nursing, Sch Nursing, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Sch Dent, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Sch Pharm, San Francisco, CA 94143 USA
关键词
chemotherapy-induced mucositis; home; patients; prevention; self-care;
D O I
10.1097/00002820-199808000-00007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Many oncology patients receive chemotherapy drugs that have the potential to induce oral mucositis. If mucositis is not prevented, patients will have to manage the problems associated with mucositis: pain, local infection, and decreased ability to take fluids or food. At the time of this writing, clinical approaches for mucositis management are variable and generally ineffective. The mouth care program, PRO-SELF(C): Mouth Aware (PSMA), presented in this article, was found to be a significant component of a self-care program that may have reduced the incidence of chemotherapy-induced mucositis. The PSMA program has three dimensions: (a) didactic information (b) development of self-care exercises (skills), and (c) supportive interactions with a nurse in the setting where the patients are receiving their treatment. This program focuses on decreasing the direct (i.e., incidence and severity of mucositis) and indirect morbidities of oral mucositis (i. e., number of local infections, level of discomfort/pain, and disruption in fluid and/or food intake). It provides the critical dimensions (i.e., specific information, self-care exercises, and nurse support) to promote the prevention of mucositis. The PSMA program is designed to provide patients with a definitive self-care repertoire to manage chemotherapy-induced mucositis in the home without the direct supervision of a health care provider.
引用
收藏
页码:263 / 268
页数:6
相关论文
共 44 条
[1]  
*AM CANC SOC, 1996, CANC FACTS FIG 1996
[2]  
Bandura A., 1977, Social Learning theory, DOI 10.1177/105960117700200317
[3]   THE EFFECTS OF SUCRALFATE SUSPENSION AND DIPHENHYDRAMINE SYRUP PLUS KAOLIN-PECTIN ON RADIOTHERAPY-INDUCED MUCOSITIS [J].
BARKER, G ;
LOFTUS, L ;
CUDDY, P ;
BARKER, B .
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS, 1991, 71 (03) :288-293
[4]   CLINICAL CHARACTERISTICS AND MECHANISMS INVOLVED IN CHEMOTHERAPY-INDUCED ORAL ULCERATION [J].
BARRETT, AP .
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS, 1987, 63 (04) :424-428
[5]  
Beck S, 1979, Cancer Nurs, V2, P185
[6]   ORAL GRAM-NEGATIVE BACILLI IN BONE-MARROW TRANSPLANT PATIENTS GIVEN CHLORHEXIDINE RINSES [J].
BROWN, AT ;
SIMS, RE ;
RAYBOULD, TP ;
LILLICH, TT ;
HENSLEE, PJ ;
FERRETTI, GA .
JOURNAL OF DENTAL RESEARCH, 1989, 68 (07) :1199-1204
[7]  
Bruya M A, 1975, Am J Nurs, V75, P1349
[8]   MANAGEMENT OF ORAL MUCOSITIS DURING LOCAL RADIATION AND SYSTEMIC CHEMOTHERAPY - A STUDY OF 98 PATIENTS [J].
CARL, W ;
EMRICH, LS .
JOURNAL OF PROSTHETIC DENTISTRY, 1991, 66 (03) :361-369
[9]   EFFECT OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR ON ORAL MUCOSITIS IN HEAD AND NECK-CANCER PATIENTS AFTER CISPLATIN, FLUOROURACIL, AND LEUCOVORIN CHEMOTHERAPY [J].
CHI, KH ;
CHEN, CH ;
CHAN, WK ;
CHOW, KC ;
CHEN, SY ;
YEN, SH ;
CHAO, JY ;
CHANG, CY ;
CHEN, KY .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (10) :2620-2628
[10]  
Daeffler R, 1980, Cancer Nurs, V3, P347